The potential role of miRNAs in the pathogenesis of salivary gland cancer–A Focus on signaling pathways interplay
Salivary gland cancer (SGC) is immensely heterogeneous, both in terms of its physical
manifestation and its aggressiveness. Developing a novel diagnostic and prognostic …
manifestation and its aggressiveness. Developing a novel diagnostic and prognostic …
Immunohistochemical markers of prognosis in non-small cell lung cancer: a review and proposal for a multiphase approach to marker evaluation
Characteristics of the tumour that affect and predict the survival outcome of patients with
cancer are prognostic markers for cancer. In non-small cell lung carcinoma (NSCLC), stage …
cancer are prognostic markers for cancer. In non-small cell lung carcinoma (NSCLC), stage …
Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma
S Gout, E Brambilla, A Boudria, R Drissi, S Lantuejoul… - 2012 - journals.plos.org
Splicing abnormalities frequently occur in cancer. A key role as splice site choice regulator is
played by the members of the SR (Ser/Arg-rich) family of proteins. We recently demonstrated …
played by the members of the SR (Ser/Arg-rich) family of proteins. We recently demonstrated …
Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy
V Ritter, F Krautter, D Klein, V Jendrossek… - Cell death & …, 2021 - nature.com
Hypoxia, a characteristic of most human solid tumors, is a major obstacle to successful
radiotherapy. While moderate acute hypoxia increases cell survival, chronic cycling hypoxia …
radiotherapy. While moderate acute hypoxia increases cell survival, chronic cycling hypoxia …
Future options of molecular-targeted therapy in small cell lung cancer
AB Schulze, G Evers, A Kerkhoff, M Mohr… - Cancers, 2019 - mdpi.com
Lung cancer is the leading cause of cancer-related deaths worldwide. With a focus on
histology, there are two major subtypes: Non-small cell lung cancer (NSCLC)(the more …
histology, there are two major subtypes: Non-small cell lung cancer (NSCLC)(the more …
Differential expression of Protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples
S Grisaru‐Granovsky, Z Salah, M Maoz… - … journal of cancer, 2005 - Wiley Online Library
Protease activated receptors (PAR) form a family of G‐protein coupled receptors (GPCR)
encoding their own ligands and uniquely activated via proteolytic cleavage. Although …
encoding their own ligands and uniquely activated via proteolytic cleavage. Although …
[HTML][HTML] Prognostic impact of Bcl-2 depends on tumor histology and expression of MALAT-1 lncRNA in non–small-cell lung cancer
LH Schmidt, D Goerlich, T Spieker, C Rohde… - Journal of Thoracic …, 2014 - Elsevier
Introduction Apoptosis is a crucial pathway in tumor growth and metastatic development.
Apoptotic proteins regulate the underlying molecular cascades and are thought to modulate …
Apoptotic proteins regulate the underlying molecular cascades and are thought to modulate …
Identification of novel deregulated RNA metabolism-related genes in non-small cell lung cancer
I Valles, MJ Pajares, V Segura, E Guruceaga… - 2012 - journals.plos.org
Lung cancer is a leading cause of cancer death worldwide. Several alterations in RNA
metabolism have been found in lung cancer cells; this suggests that RNA metabolism …
metabolism have been found in lung cancer cells; this suggests that RNA metabolism …
High expression of BCL-2 predicts favorable outcome in non-small cell lung cancer patients with non squamous histology
Background Bcl-2 promotes cell survival by inhibiting adapters needed for the activation and
cleavage of caspases thus blocking the proteolytic cascade that ultimately dismantles the …
cleavage of caspases thus blocking the proteolytic cascade that ultimately dismantles the …
Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma
SG Sanchez-Ceja, E Reyes-Maldonado… - Lung Cancer, 2006 - Elsevier
Experimental evidence suggests that in lung cancer, development, progression and an
increased proliferation rate can be linked to apoptosis-related factors. The objective of this …
increased proliferation rate can be linked to apoptosis-related factors. The objective of this …